Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Why AbbVie Stock Trounced the Market in 2025
Is AbbVie (ABBV) Pricing Reflect Its DCF And Price To Sales Signals After Recent Gains
AbbVie's Irish operations in firing line as Trump targets Botox prices
AbbVie Inc. $ABBV Shares Bought by Mirae Asset Global Investments Co. Ltd.
AbbVie (NYSE:ABBV) Shares Down 2.2% on Analyst Downgrade - Daily Political
Skin Boosters Market to Surpass USD 3,263.80 Million by 2032, Shows New Analysis on Injectable Skin Rejuvenation and Anti-Aging Trends: MMR Statistics
AbbVie Inc. $ABBV Shares Bought by Federated Hermes Inc.
AbbVie Inc. $ABBV Shares Sold by Bank of New York Mellon Corp
Truist Financial Corp Acquires 124,756 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (ABBV) to Release Quarterly Earnings on Wednesday
Does AbbVie's Bispecific Trial Win and R&D Pledge Change The Bull Case For AbbVie (ABBV)?
AbbVie (NYSE:ABBV) Shares Up 1.4% - Still a Buy?
AbbVie Pricing Pact And Cancer Trial Data Reframe Long Term Outlook
TGA issues fake Botox warning over 'significant' health risks
Final Trades: AbbVie, SLB, Amphenol and the IYH
AbbVie (NYSE:ABBV) Price Target Cut to $230.00 by Analysts at Citigroup - Stock Observer
Berenberg Grows More Confident in AbbVie (ABBV) on Skyrizi and Rinvoq Momentum
Why Revolution Medicines Stock Plummeted by Almost 17% Today
RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
How Recent Price Target Rethinks Are Rewriting The Story For AbbVie (ABBV)
AbbVie Inc. $ABBV Shares Sold by Parthenon LLC | MarketBeat
AbbVie Inc. $ABBV Stake Cut by Lbp Am Sa | MarketBeat
AbbVie Inc. $ABBV Position Cut by Mutual of America Capital Management LLC
Lbp Am Sa Sells 49,377 Shares of AbbVie Inc. $ABBV - Stock Observer
Mutual of America Capital Management LLC Has $47.50 Million Stake in AbbVie Inc. $ABBV - Stock Observer
Vanguard Personalized Indexing Management LLC Increases Stock Position in AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Shares Sold by Parthenon LLC - Daily Political
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials
Sagespring Wealth Partners LLC Has $8.81 Million Holdings in AbbVie Inc. $ABBV - Daily Political
WST: 2026 Drug Delivery Focus And New Syringe Platform Will Support Earnings Power
TrueMark Investments LLC Lowers Position in AbbVie Inc. $ABBV
ABBV: Future Returns Will Hinge On Post-Humira Immunology And Deal Optionality
Mitsubishi UFJ Trust & Banking Corp Has $260.35 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
Resona Asset Management Co. Ltd. Lowers Holdings in AbbVie Inc. $ABBV - Stock Observer
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio
Strs Ohio Increases Stake in AbbVie Inc. $ABBV - Markets Daily
3 Stocks Including Datadog That May Be Priced Below Their Estimated Value
AbbVie Inc. $ABBV Shares Purchased by Strs Ohio - Stock Observer
Assessing AbbVie (ABBV) Valuation After Positive Phase 3 Epcoritamab Lymphoma Results
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income
AbbVie Inc. $ABBV Shares Sold by Simplicity Wealth LLC
AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of "Moderate Buy" from Analysts
AbbVie Cancer Updates Highlight Epcoritamab Data And RC148 Deal For Investors
Diagnosis, risk stratification and management of smouldering multiple myeloma
AbbVie is a top dividend stock as drug pipelines drive payout hikes
208,510 Shares in AbbVie Inc. $ABBV Purchased by Rakuten Investment Management Inc.
Vest Financial LLC Has $72.41 Million Position in AbbVie Inc. $ABBV
Bailard Inc. Acquires 16,049 Shares of AbbVie Inc. $ABBV
Vest Financial LLC Has $72.41 Million Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Migdal Insurance & Financial Holdings Ltd. - Daily Political
Bernstein Sticks to Their Hold Rating for AbbVie (ABBV) | Markets Insider
Inflammation and pain as interconnected targets in axial spondyloarthritis
Dividend Stocks To Follow Now - January 20th - Markets Daily
6 JPM Healthcare Conference Announcements You Don't Want to Miss - Dealbreaker
Vaughan David Investments LLC IL Has $77.91 Million Stock Position in AbbVie Inc. $ABBV
Dynasty Wealth Management LLC Takes Position in AbbVie Inc. $ABBV
Vaughan David Investments LLC IL Has $77.91 Million Stake in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Arkadios Wealth Advisors
REGENXBIO Inc. (RGNX): A Bull Case Theory
Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback
Autoimmune ADC: On the Verge of an Explosion
Violich Capital Management Inc. Grows Position in AbbVie Inc. $ABBV
Axecap Investments LLC Sells 25,567 Shares of AbbVie Inc. $ABBV
Allstate Corp Has $14.87 Million Holdings in AbbVie Inc. $ABBV
FY2025 Earnings Forecast for AbbVie Issued By Zacks Research
Best Medical Stocks To Research - January 18th - Markets Daily
Rep. Julie Johnson Sells AbbVie Inc. (NYSE:ABBV) Stock - Daily Political
Amalgamated Bank Raises Stock Position in AbbVie Inc. $ABBV
Sequoia Financial Advisors LLC Purchases 4,485 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Stegent Equity Advisors Inc. - Daily Political
AbbVie Inc. $ABBV Shares Sold by WoodTrust Financial Corp
QRG Capital Management Inc. Lowers Position in AbbVie Inc. $ABBV - Markets Daily
Leavell Investment Management Inc. Sells 3,208 Shares of AbbVie Inc. $ABBV - Markets Daily
QRG Capital Management Inc. Sells 75,094 Shares of AbbVie Inc. $ABBV - Stock Observer
Leavell Investment Management Inc. Sells 3,208 Shares of AbbVie Inc. $ABBV - Stock Observer
Stock Traders Purchase Large Volume of Call Options on AbbVie (NYSE:ABBV) - Stock Observer
AbbVie Inc. $ABBV Shares Bought by Pinnacle Financial Partners Inc - Daily Political
Genmab and AbbVie Drug for Blood Cancer Fails Late-Stage Trial, ETPharma
AbbVie (NYSE:ABBV) Stock Price Down 1.1% - Time to Sell?
Company Announcement Based on the topline results from the
Pharmaceutical Stocks To Keep An Eye On - January 16th - Markets Daily
How Investors May Respond To AbbVie (ABBV) $100 Billion U.S. Investment And Drug Pricing Pact
Zacks Research Comments on AbbVie's Q1 Earnings (NYSE:ABBV)
Rep. Julia Letlow Sells AbbVie Inc. (NYSE:ABBV) Stock - Markets Daily
Investors Purchase Large Volume of AbbVie Call Options (NYSE:ABBV)
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel
AbbVie (NYSE:ABBV) Shares Down 2.4% - Time to Sell?
Assessing RemeGen (SEHK:9995) Valuation After AbbVie RC148 Licensing Agreement
AbbVie Inc. $ABBV Shares Bought by Meritage Portfolio Management
Conning Inc. Decreases Position in AbbVie Inc. $ABBV
Rep. Julia Letlow Sells Off Shares of AbbVie Inc. (NYSE:ABBV)
Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness
Kera Capital Partners Inc. Acquires Shares of 8,391 AbbVie Inc. $ABBV - Markets Daily
Stephens Inc. AR Boosts Position in AbbVie Inc. $ABBV
Robeco Schweiz AG Cuts Holdings in AbbVie Inc. $ABBV - Markets Daily
AbbVie News
Gold price prediction 2026: Will gold (XAU) touch new highs in coming days?
Trending cryptos prediction: BTC recovers, ETH and XRP under pressure
Gold CFD trading tips for beginners: 5 steps to investing in gold in 2026
RIVN stock price prediction: RIVN crashes 31%, is Rivian a buy sell or hold?
TTD stock is trading down 7% today: What’s happening with Trade Desk Inc?
